INMB

INmune Bio Inc.

8.07 USD
-0.01 (-0.12%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

INmune Bio Inc. stock is up 8.91% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 July’s closed higher than June. In the last 3 Unusual Options Trades, there were 2 PUTs, 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
04 Jun 14:53 20 Dec, 2024 15.00 PUT 80 0
26 Jun 14:52 20 Dec, 2024 5.00 CALL 100 41
09 Jul 18:07 20 Sep, 2024 10.00 PUT 95 29

About INmune Bio Inc.

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation.